Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis. 1979

J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
Department of Medicine, Tufts--New England Medical Center, Boston, Massachusetts 02111.

The in vitro activities of cephalothin and cefoxitin against Bacteroides fragilis were studied by time-kill curves and measurement of residual drugs in culture supernatants. Cefoxitin was bactericidal, causing a decrease of 10(7) in viable counts over 24 hr. Cephalothin caused an initial decrease of 10(2) B. fragilis at 2 hr; this change was followed by growth of the organism within 24 hr back to the number present before addition of cephalothin. The concentration of cephalothin in broth decreased rapidly within 2 hr and was undetectable within 24 hr, whereas the level of cefoxitin decreased only 25% over the 24-hr period. Penetration of these drugs into perforated ping pong balls implanted intraperitoneally in rabbits was studied. Three weeks after implantation the reservoirs were infected with B. fragilis. After intramuscular administration of five doses of antibiotic, the penetration of cephalothin, as measured by bioassay, in uninfected and infected capsules was 16% and 2%, respectively, of the peak serum concentration; similar findings were noted with cefoxitin. For determination of the rate of breakdown within the infected site, radiolabeled antibiotic was injected into the capsule, and the concentrations of bioactive and radioactive drug were determined. With radiolabeled cephalothin there was a rapid decrease in bioactivity during the initial 60 min, and no active drug was measurable after 2 hr. In contrast, only 40% of cefoxitin was inactivated at the end of 6 hr. The results indicate that levels of cephalothin and cefoxitin are reduced significantly in sites infected with B. fragilis. The decrease appears to be mediated by both a decrease in penetration and inactivation at the site of infection.

UI MeSH Term Description Entries
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002512 Cephalothin A cephalosporin antibiotic. Cefalotin,Sodium Cephalothin,Cefalotina Normon,Cefalotina Sodica Spaly,Ceftina,Cephalothin Monosodium Salt,Keflin,Seffin,Cephalothin, Sodium,Monosodium Salt, Cephalothin,Salt, Cephalothin Monosodium
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D001442 Bacteroides Infections Infections with bacteria of the genus BACTEROIDES. Infections, Bacteroides,Bacteroides Infection,Infection, Bacteroides

Related Publications

J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
July 1981, The Journal of antimicrobial chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
September 1981, Antimicrobial agents and chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
December 1983, Antimicrobial agents and chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
August 1975, Antimicrobial agents and chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
April 1989, The Journal of antimicrobial chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
June 1987, Diagnostic microbiology and infectious disease,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
October 1984, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
December 1978, Archives of ophthalmology (Chicago, Ill. : 1960),
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
January 1985, Chemotherapy,
J P O'Keefe, and F P Tally, and M Barza, and S L Gorbach
May 1986, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!